Literature DB >> 28126575

Low levels of serum total antioxidant capacity and presence at admission and absence at discharge of a day/night change as a marker of acute paranoid schizophrenia relapse.

Armando L Morera-Fumero1, Estefanía Díaz-Mesa2, Pedro Abreu-Gonzalez3, Lourdes Fernandez-Lopez4, Maria Del Rosario Cejas-Mendez2.   

Abstract

BACKGROUND: An oxidant-antioxidant system dysregulation has been described as a schizophrenia pathophysiological base. The total antioxidant capacity (TAC) is one measure of the antioxidant capacity of a system. Day/night concentration changes is a biological characteristic of hormones such as melatonin or cortisol. There is no information about TAC day/night changes in schizophrenia. AIMS: Studying the existence of a day/night TAC change in schizophrenia.
METHOD: Forty-three DSM-IV paranoid schizophrenia inpatients participated in the study. Thirty healthy subjects matched by age and gender acted as control group. Blood was sampled at 12:00 and 00:00h the day after admission and the day before discharge. Serum TAC was measured by the ABTS radical cation technique and expressed in Trolox mmol/L.
RESULTS: Patients had significantly lower TAC levels at admission and discharge (12:00 and 00:00) than controls. At admission patients had a TAC day/night change, with higher day-time than night-time levels (0.66±0.14 vs 0.60±0.15) as well as healthy subjects (0.83±0.07 vs 0.77±0.11). At discharge patients had a similar TAC level at 12:00 and 00:00 (0.64±0.15 vs 0.63±0.14).
CONCLUSION: Schizophrenic patients present a deficit of the antioxidant system. The initial presence and the later absence of a day/night change deserves future studies.
Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Acute relapse; Biological markers; Day/night changes; Methodology; Oxidant-antioxidant system; Schizophrenia; Total antioxidant capacity

Mesh:

Substances:

Year:  2017        PMID: 28126575     DOI: 10.1016/j.psychres.2017.01.043

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  8 in total

1.  Serum Oxidative Stress Marker Levels in Unmedicated and Medicated Patients with Schizophrenia.

Authors:  Zhi-Le Bai; Xue-Song Li; Guang-Yang Chen; Yang Du; Ze-Xu Wei; Xi Chen; Guang-En Zheng; Wen Deng; Yong Cheng
Journal:  J Mol Neurosci       Date:  2018-10-09       Impact factor: 3.444

Review 2.  Does Vitamin C Influence Neurodegenerative Diseases and Psychiatric Disorders?

Authors:  Joanna Kocot; Dorota Luchowska-Kocot; Małgorzata Kiełczykowska; Irena Musik; Jacek Kurzepa
Journal:  Nutrients       Date:  2017-06-27       Impact factor: 5.717

3.  A three-month longitudinal study of changes in day/night serum total antioxidant capacity in paranoid schizophrenia.

Authors:  Armando L Morera-Fumero; Estefanía Díaz-Mesa; Pedro Abreu-Gonzalez; Lourdes Fernandez-Lopez; Fernando Guillen-Pino
Journal:  PLoS One       Date:  2017-12-08       Impact factor: 3.240

4.  Polycystic ovarian syndrome is linked to increased oxidative stress in Omani women.

Authors:  Maha Ah Sulaiman; Yahya M Al-Farsi; Maha M Al-Khaduri; Jumana Saleh; Mostafa I Waly
Journal:  Int J Womens Health       Date:  2018-11-28

5.  Obesity, altered oxidative stress, and clinical correlates in chronic schizophrenia patients.

Authors:  Huimei An; Xiangdong Du; Xingbing Huang; Lingyan Qi; Qiufang Jia; Guangzhong Yin; Chunling Xiao; Xu-Feng Huang; Yuping Ning; Ryan M Cassidy; Li Wang; Jair C Soares; Xiang Yang Zhang
Journal:  Transl Psychiatry       Date:  2018-11-29       Impact factor: 6.222

Review 6.  Oxidative-Antioxidant Imbalance and Impaired Glucose Metabolism in Schizophrenia.

Authors:  Amira Bryll; Justyna Skrzypek; Wirginia Krzyściak; Maja Szelągowska; Natalia Śmierciak; Tamas Kozicz; Tadeusz Popiela
Journal:  Biomolecules       Date:  2020-03-02

7.  Day/Night and Summer/Winter Changes in Serum Total Antioxidant Capacity.

Authors:  Armando L Morera-Fumero; Pedro Abreu-Gonzalez; Manuel Henry-Benitez; Lourdes Fernandez-Lopez; Estefania Diaz-Mesa; Maria Del Rosario Cejas-Mendez; Fernando Guillen-Pino
Journal:  Med Chem       Date:  2018       Impact factor: 2.745

Review 8.  Potential Novel Therapies for Neurodevelopmental Diseases Targeting Oxidative Stress.

Authors:  Alexandrina S Curpan; Alina-Costina Luca; Alin Ciobica
Journal:  Oxid Med Cell Longev       Date:  2021-07-22       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.